Drug Delivery
High-quality activated PEGs and phospholipids developed for use in drug delivery systems (DDS) serving pharmaceutical and medical device applications. NOF AMERICA provides materials with controlled specifications and consistent quality to support complex delivery designs and advanced therapeutic development.
Four material segments supporting diverse delivery strategies
Drug Delivery Systems (DDS) Portfolio
-
Activated PEG for PEGylation
Activated PEG are popular conjugating agents for proteins and other pharmaceutical substances to improve their solubility. Recently, these PEGs are also applied for hydrogel components.
-
Phospholipids and Lipids for LNP and Liposome
High-purity phospholipids and lipids for LNP & liposome drug delivery — custom-synthesized under cGMP, ideal for gene therapy, mRNA vaccines & pharma formulation.
-
UltraPure Polysorbate 80
High-purity Polysorbate 80 (HX2)™ — low-impurity, compliant with USP/NF, EP and JP. A premium excipient for stable emulsions, injectables, vaccines, and pharmaceutical formulations.
-
Novel Excipients for Pharmaceutical Development
Premium novel excipients that support advanced pharmaceutical formulation, offering improved stability, solubility and reliability for modern drug development needs.
Biodegradable Lipid Nanoparticles for mRNA Delivery
This video introduces NOF’s biodegradable lipid nanoparticle (LNP) technologies designed for mRNA delivery and vaccine applications. Using specialized ionizable lipids, NOF’s LNP platforms enable high encapsulation efficiency, enhanced gene expression, and targeted delivery while maintaining a strong safety profile.
These technologies have been demonstrated across a range of applications, including ex-vivo and in-vivo delivery of siRNA, mRNA, and DNA, as well as mRNA-based vaccines, highlighting NOF’s advanced capabilities within drug delivery systems.